Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Philip Andreas Schytz"'
Autor:
Philip Andreas Schytz, Paul Blanche, Anders Bonde Nissen, Christian Torp-Pedersen, Gunnar H. Gislason, Karl Emil NELVEG-Kristensen, Kristine Hommel, Nicholas Carlson
Publikováno v:
Nefrología (English Edition), Vol 42, Iss 3, Pp 338-346 (2022)
Background: Acute kidney injury (AKI) has been associated with cardiovascular disease, but this is sparsely studied in non-selected populations and with little attention to the effect in age and renal function. Using nationwide administrative data, w
Externí odkaz:
https://doaj.org/article/e09760eaa06c42d68857198d1c53f450
Autor:
Frederik F. Kreiner, Philip Andreas Schytz, Hiddo J. L. Heerspink, Bernt Johan von Scholten, Thomas Idorn
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2498 (2023)
Obesity is a serious chronic disease and an independent risk factor for the new onset and progression of chronic kidney disease (CKD). CKD prevalence is expected to increase, at least partly due to the continuous rise in the prevalence of obesity. Th
Externí odkaz:
https://doaj.org/article/b992077fcd914823b4e3a831ed8cf741
Autor:
Gunnar Gislason, Anders Bonde Nissen, Paul Blanche, Philip Andreas Schytz, Nicholas Carlson, Karl Emil Nelveg-Kristensen, Christian Torp-Pedersen, Kristine Hommel
Publikováno v:
Schytz, P A, Blanche, P, Nissen, A B, Torp-Pedersen, C, Gislason, G H, Nelveg-Kristensen, K E, Hommel, K & Carlson, N 2022, ' Acute kidney injury and risk of cardiovascular outcomes : A nationwide cohort study ', Nefrologia, vol. 42, no. 3, pp. 338-346 . https://doi.org/10.1016/j.nefro.2021.06.007
BACKGROUND: Acute kidney injury (AKI) has been associated with cardiovascular disease, but this is sparsely studied in non-selected populations and with little attention to the effect in age and renal function. Using nationwide administrative data, w
Autor:
Karl Emil Nelveg-Kristensen, Gunnar Gislason, Kristine Hommel, Thomas A. Gerds, Anders Bonde Nissen, Morten Schou, Philip Andreas Schytz, Nicholas Carlson, Christian Torp-Pedersen
Publikováno v:
Journal of Nephrology. 34:709-717
Despite the long-term renoprotective effects of Metformin, a recent study on data from the U.S. Food and Drug Administration reported a possible nephrotoxic effect, contributing to the development of acute kidney injury (AKI). We investigated the ass
Autor:
Philip Andreas Schytz, Paul Blanche, Anders Bonde Nissen, Christian Torp-Pedersen, Gunnar H. Gislason, Karl Emil NELVEG-Kristensen, Kristine Hommel, Nicholas Carlson
Publikováno v:
Nefrologia. 42(3)
Acute kidney injury (AKI) has been associated with cardiovascular disease, but this is sparsely studied in non-selected populations and with little attention to the effect in age and renal function. Using nationwide administrative data, we investigat
Autor:
Kristine Hommel, Gunnar Gislason, Christian Torp-Pedersen, Anders Bonde Nissen, Karl Emil Nelveg-Kristensen, Nicholas Carlson, Philip Andreas Schytz, Thomas A. Gerds
Publikováno v:
Journal of hypertension. 38(12)
Objective Abrupt decline in renal function following initiation of renin-angiotensin system inhibitor is associated with increased risk of cardiovascular disease, but studies of other antihypertensive drugs are sparse. We investigated the risk of car
Autor:
Gunnar Gislason, Anne-Lise Kamper, Christian Torp-Pedersen, Philip Andreas Schytz, Thomas S. G. Sehested, Nicholas Carlson, Karl Emil Nelveg-Kristensen, Mavish S. Chaudry
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Philip Andreas Schytz, Anders Bonde Nissen, Kristine Hommel, Morten Schou, Karl Emil Nelveg-Kristensen, Christian Torp-Pedersen, Gunnar H. Gislason, Thomas A. Gerds, Nicholas Carlson
Publikováno v:
Journal of Nephrology. 34:1381-1381
Autor:
Henrik Post Hansen, Bent Kristensen, Maria L. Mace, Søren Daustrand Ladefoged, Philip Andreas Schytz, Anne Merete Boas Soja, Brian Nilsson, Nikolaos Karamperis
Publikováno v:
Nephrology Dialysis Transplantation. 30:2075-2079
BACKGROUND If blood pressure (BP) falls during haemodialysis (HD) [intradialytic hypotension (IDH)] a common clinical practice is to reduce the extracorporeal blood flow rate (EBFR). Consequently the efficacy of the HD (Kt/V) is reduced. However, onl